ContractNivalis Therapeutics, Inc. • February 13th, 2015 • Pharmaceutical preparations • Delaware
Company FiledFebruary 13th, 2015 Industry JurisdictionTHIS WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED OR ANY STATE SECURITIES LAWS. NO SALE OR DISPOSITION MAY BE EFFECTED WITHOUT (i) EFFECTIVE REGISTRATION STATEMENTS RELATED THERETO, (ii) AN OPINION OF COUNSEL OR OTHER EVIDENCE, REASONABLY SATISFACTORY TO THE COMPANY, THAT SUCH REGISTRATIONS ARE NOT REQUIRED, (iii) RECEIPT OF NO-ACTION LETTERS FROM THE APPROPRIATE GOVERNMENTAL AUTHORITIES, OR (iv) OTHERWISE COMPLYING WITH THE PROVISIONS OF SECTION 7 OF THIS WARRANT.
N30 PHARMACEUTICALS, INC. STOCK OPTION AGREEMENT2012 Stock Incentive Plan • February 13th, 2015 • Nivalis Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledFebruary 13th, 2015 Company Industry JurisdictionN30 Pharmaceuticals, Inc. (the “Company”) hereby grants to the Grantee listed below (the “Grantee”) an option (the “Option”) to purchase the number shares of Common Stock (“Stock”) of the Company set forth below, subject to the terms and conditions of the Plan and this Stock Option Agreement (the “Option Agreement”) including the Exhibits attached hereto, as follows:
SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • February 13th, 2015 • Nivalis Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 13th, 2015 Company Industry JurisdictionTHIS SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (this “Agreement”) is made as of November 18, 2014, by and among N30 Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each of the holders of capital stock of the Company listed on Schedule A hereto (each a “Stockholder” and together the “Stockholders”).
FIRST AMENDMENT TO LEASELease • February 13th, 2015 • Nivalis Therapeutics, Inc. • Pharmaceutical preparations • Colorado
Contract Type FiledFebruary 13th, 2015 Company Industry JurisdictionTHIS FIRST AMENDMENT TO LEASE (this “Amendment”) is made effective as of the 5th day of December, 2014, by and between AWEIDA PROPERTIES, INC., a Colorado corporation (“Landlord”), and N30 PHARMACEUTICALS, INC. a Delaware Corporation (“Tenant”) to that certain lease dated March 11, 2010 by and between Landlord and Tenant (the “Lease”). Capitalized terms used herein which are defined in the Lease shall have the meanings therein stated.
LEASELease • February 13th, 2015 • Nivalis Therapeutics, Inc. • Pharmaceutical preparations • Colorado
Contract Type FiledFebruary 13th, 2015 Company Industry Jurisdiction